Meta-analysis of estrogen response in MCF-7 distinguishes early target genes involved in signaling and cell proliferation from later target genes involved in cell cycle and DNA repair

BackgroundMany studies have been published outlining the global effects of 17β-estradiol (E2) on gene expression in human epithelial breast cancer derived MCF-7 cells. These studies show large variation in results, reporting between ~100 and ~1500 genes regulated by E2, with poor overlap.ResultsWe performed a meta-analysis of these expression studies, using the Rank product method to obtain a more accurate and stable list of the differentially expressed genes, and of pathways regulated by E2. We analyzed 9 time-series data sets, concentrating on response at 3-4 hrs (early) and at 24 hrs (late). We found >1000 statistically significant probe sets after correction for multiple testing at 3-4 hrs, and >2000 significant probe sets at 24 hrs. Differentially expressed genes were examined by pathway analysis. This revealed 15 early response pathways, mostly related to cell signaling and proliferation, and 20 late response pathways, mostly related to breast cancer, cell division, DNA repair and recombination.ConclusionsOur results confirm that meta-analysis identified more differentially expressed genes than the individual studies, and that these genes act together in networks. These results provide new insight into E2 regulated mechanisms, especially in the context of breast cancer.

[1]  Leighton J. Core,et al.  A Rapid, Extensive, and Transient Transcriptional Response to Estrogen Signaling in Breast Cancer Cells , 2011, Cell.

[2]  Sangsoo Kim,et al.  Combining multiple microarray studies and modeling interstudy variation , 2003, ISMB.

[3]  A. Fabiato,et al.  Anonymity of reviewers , 1994 .

[4]  Michael Karin,et al.  NF-kappaB and cancer-identifying targets and mechanisms. , 2008, Current opinion in genetics & development.

[5]  R. Koos,et al.  Inhibition of oxygen-induced hypoxia-inducible factor-1alpha degradation unmasks estradiol induction of vascular endothelial growth factor expression in ECC-1 cancer cells in vitro. , 2009, Endocrinology.

[6]  Aleksandra M. Michalowska,et al.  Identification of an integrated SV40 T/t-antigen cancer signature in aggressive human breast, prostate, and lung carcinomas with poor prognosis. , 2007, Cancer research.

[7]  S. Hilsenbeck,et al.  Global gene expression analysis of estrogen receptor transcription factor cross talk in breast cancer: identification of estrogen-induced/activator protein-1-dependent genes. , 2005, Molecular endocrinology.

[8]  E. Cheung,et al.  Genomic analyses of hormone signaling and gene regulation. , 2010, Annual review of physiology.

[9]  F. Stossi,et al.  Whole-Genome Cartography of Estrogen Receptor α Binding Sites , 2007, PLoS genetics.

[10]  Chin-Yo Lin,et al.  Gene expression preferentially regulated by tamoxifen in breast cancer cells and correlations with clinical outcome. , 2006, Cancer research.

[11]  Barry Komm,et al.  Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype. , 2003, Endocrinology.

[12]  Dennis B. Troup,et al.  NCBI GEO: mining tens of millions of expression profiles—database and tools update , 2006, Nucleic Acids Res..

[13]  John H. White,et al.  Mechanisms of primary and secondary estrogen target gene regulation in breast cancer cells , 2007, Nucleic acids research.

[14]  H. Stunnenberg,et al.  Genomic actions of estrogen receptor alpha: what are the targets and how are they regulated? , 2009, Endocrine-related cancer.

[15]  H. Stunnenberg,et al.  ChIP‐Seq of ERα and RNA polymerase II defines genes differentially responding to ligands , 2009, The EMBO journal.

[16]  W. Kraus,et al.  A Global View of Transcriptional Regulation by Nuclear Receptors: Gene Expression, Factor Localization, and DNA Sequence Analysis , 2008, Nuclear receptor signaling.

[17]  M. Hendrix,et al.  IRF6 in development and disease: A mediator of quiescence and differentiation , 2008, Cell cycle.

[18]  E. Ariazi,et al.  ERE-independent ERα target genes differentially expressed in human breast tumors , 2005, Molecular and Cellular Endocrinology.

[19]  J. Frasor,et al.  Impact of estrogen receptor beta on gene networks regulated by estrogen receptor alpha in breast cancer cells. , 2006, Endocrinology.

[20]  Barry Komm,et al.  Estrogen Receptors (cid:1) and (cid:2) as Determinants of Gene Expression: Influence of Ligand, Dose, and Chromatin Binding , 2008 .

[21]  Erratum: Identification of an integrated SV40 T/t-antigen cancer signature in aggressive human breast, prostate, and lung carcinomas with poor prognosis (Cancer Research (2007) 67, (8065-8080)) , 2007 .

[22]  Rainer Breitling,et al.  RankProd: a bioconductor package for detecting differentially expressed genes in meta-analysis , 2006, Bioinform..

[23]  Lorenzo Ferraro,et al.  Estrogen receptor alpha controls a gene network in luminal-like breast cancer cells comprising multiple transcription factors and microRNAs. , 2010, The American journal of pathology.

[24]  Rainer Breitling,et al.  Rank products: a simple, yet powerful, new method to detect differentially regulated genes in replicated microarray experiments , 2004, FEBS letters.

[25]  Rafael A Irizarry,et al.  Exploration, normalization, and summaries of high density oligonucleotide array probe level data. , 2003, Biostatistics.

[26]  J. Frasor,et al.  Impact of Estrogen Receptor β on Gene Networks Regulated by Estrogen Receptor α in Breast Cancer Cells , 2006 .

[27]  Karin Kovar,et al.  Promoter library designed for fine-tuned gene expression in Pichia pastoris , 2008, Nucleic acids research.

[28]  Arul M Chinnaiyan,et al.  Genes regulated by estrogen in breast tumor cells in vitro are similarly regulated in vivo in tumor xenografts and human breast tumors , 2006, Genome Biology.

[29]  Rainer Breitling,et al.  A comparison of meta-analysis methods for detecting differentially expressed genes in microarray experiments , 2008, Bioinform..

[30]  John Quackenbush,et al.  Multiple-laboratory comparison of microarray platforms , 2005, Nature Methods.

[31]  E. Ariazi,et al.  ERE-independent ERalpha target genes differentially expressed in human breast tumors. , 2005, Molecular and cellular endocrinology.

[32]  Rafael A. Irizarry,et al.  A Model-Based Background Adjustment for Oligonucleotide Expression Arrays , 2004 .

[33]  B. Katzenellenbogen.  Estrogen receptors: bioactivities and interactions with cell signaling pathways. , 1996, Biology of reproduction.

[34]  Neil J McKenna,et al.  GEMS (Gene Expression MetaSignatures), a Web resource for querying meta-analysis of expression microarray datasets: 17beta-estradiol in MCF-7 cells. , 2009, Cancer research.

[35]  Giancarlo Mauri,et al.  A comparison of machine learning techniques for survival prediction in breast cancer , 2011, BioData Mining.

[36]  S. Safe,et al.  Transcriptional activation of transforming growth factor alpha by estradiol: requirement for both a GC-rich site and an estrogen response element half-site. , 2000, Journal of molecular endocrinology.

[37]  S. Badve,et al.  NF-κB represses E-cadherin expression and enhances epithelial to mesenchymal transition of mammary epithelial cells: potential involvement of ZEB-1 and ZEB-2 , 2007, Oncogene.

[38]  Allen Chong,et al.  Discovery of estrogen receptor α target genes and response elements in breast tumor cells , 2004, Genome Biology.

[39]  Clifford A. Meyer,et al.  Genome-wide analysis of estrogen receptor binding sites , 2006, Nature Genetics.

[40]  D. Kalaitzidis,et al.  Transcription factor cross-talk: the estrogen receptor and NF-kappaB. , 2005, Trends in endocrinology and metabolism: TEM.

[41]  Marc E. Lippman,et al.  GREB1 is a critical regulator of hormone dependent breast cancer growth , 2005, Breast Cancer Research and Treatment.

[42]  J. Gustafsson,et al.  Estrogen receptor and aryl hydrocarbon receptor signaling pathways , 2006, Nuclear receptor signaling.

[43]  A. Nardulli,et al.  Sp1 binding sites and an estrogen response element half-site are involved in regulation of the human progesterone receptor A promoter. , 2000, Molecular endocrinology.

[44]  T. Kroll,et al.  Gene expression profiling reveals effects of Cimicifuga racemosa (L.) NUTT. (black cohosh) on the estrogen receptor positive human breast cancer cell line MCF-7 , 2007, BMC pharmacology.

[45]  D. Kalaitzidis,et al.  Transcription factor cross-talk: the estrogen receptor and NF-κB , 2005, Trends in Endocrinology & Metabolism.